Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23d7114761126a24b0450f59dba42bc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9208ad4179e3c0d9125d342f1be9e46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1f628fa19f4043fb84685d00eb764e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da512e94ab6e23c58dc0f3e871319512 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1eaa06d9a0cd593bf7bb48e1ab6f9161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b82f96f476d23a7668947a83cdaefcc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40b595f67aca333e1ddb5db8f356de31 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19 |
filingDate |
2008-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4116f7d288ff951cacf6f189afaa3b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa165a08a6ee4a31f4a8ae39cd61c751 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d686bdf7d24d3e93cf570b3a7a6cef40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_165f54fb97e89206fb5cd781c6cece1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15fa0f9dd2977676135d94887ece1eef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e746807a52a3500070aebee9b2a85736 |
publicationDate |
2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8221745-B2 |
titleOfInvention |
Prolonging survival of platelets using CMP-sialic acid,UDP-galactose or both |
abstract |
The present invention provides modified platelets having a reduced platelet clearance and methods for reducing platelet clearance. Also provided are compositions for the preservation of platelets. The invention also provides methods for making a pharmaceutical composition containing the modified platelets and for administering the pharmaceutical composition to a mammal to mediate hemostasis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11197893-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009074737-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012107791-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8517967-B2 |
priorityDate |
2004-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |